ArticleCyborg and bionic systems (Washington, D.C.)2024
Interlimb and Intralimb Synergy Modeling for Lower Limb Assistive Devices: Modeling Methods and Feature Selection.
Article in Cyborg and bionic systems (Washington, D.C.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A Single-Source Dual-Drive Flexible Knee Assistive Exoskeleton for Elderly Daily Locomotion.Cyborg and bionic systems (Washington, D.C.) · 2026Article
- Continuous Lower Limb Biomechanics Prediction via Prior-Informed Lightweight Marker-GMformer.Cyborg and bionic systems (Washington, D.C.) · 2026Article
- Implementing ensemble of deep learning model with optimization techniques for human activity recognition to assist individuals with disabilities.Scientific reports · 2025Article
- Exploring the potential of bacterial-derived EVs for targeted enzyme replacement therapy: mechanisms, applications, and future directions.Archives of microbiology · 2025Review
- Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implications.Biogerontology · 2025Review
- Exploring New Tools in Upper Limb Rehabilitation After Stroke Using an Exoskeletal Aid: A Pilot Randomized Control Study.Healthcare (Basel, Switzerland) · 2025Article
- Multi-Exoskeleton Performance Evaluation: Integrated Muscle Energy Indices to Determine the Quality and Quantity of Assistance.Bioengineering (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concept of gait synergy provides novel human-machine interfaces and has been applied to the control of lower limb assistive devices, such as powered prostheses and exoskeletons. Specifically, on the basis of gait synergy, the assistive device can generate/predict the appropriate reference trajectories precisely for the affected or missing parts from the motions of sound parts of the patients. Optimal modeling for gait synergy methods that involves optimal combinations of features (inputs) is required to achieve synergic trajectories that improve human-machine interaction. However, previous studies lack thorough discussions on the optimal methods for synergy modeling. In addition, feature selection (FS) that is crucial for reducing data dimensionality and improving modeling quality has often been neglected in previous studies. Here, we comprehensively investigated modeling methods and FS using 4 up-to-date neural networks: sequence-to-sequence (Seq2Seq), long short-term memory (LSTM), recurrent neural network (RNN), and gated recurrent unit (GRU). We also conducted complete FS using 3 commonly used methods: random forest, information gain, and Pearson correlation. Our findings reveal that Seq2Seq (mean absolute error: 0.404° and 0.596°, respectively) outperforms LSTM, RNN, and GRU for both interlimb and intralimb synergy modeling. Furthermore, FS is proven to significantly improve Seq2Seq's modeling performance (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.